nalbuphine (PHN-131)
/ PhytoHealth Corp
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 21, 2023
Safety and Efficacy of Oral Nalbuphine on Postoperative Pain in Hemorrhoidectomy Patients: A Randomized, Double-blind, Placebo-controlled, Pivotal Trial.
(PubMed, Clin J Pain)
- "Our findings demonstrate that PHN131 is effective and well-tolerated in the treatment of moderate-to-severe post hemorrhoidectomy pain and may provide another option for patients to control their pain."
Clinical • Journal • Addiction (Opioid and Alcohol) • CNS Disorders • Depression • Gastroenterology • Pain • Psychiatry
March 29, 2022
A Single Bolus of Dexmedetomidine Versus Nalbuphine in Postoperative Agitation
(clinicaltrials.gov)
- P3 | N=90 | Recruiting | Sponsor: Assiut University | Trial completion date: Dec 2021 ➔ Dec 2023 | Trial primary completion date: Dec 2021 ➔ Oct 2023
Trial completion date • Trial primary completion date
August 28, 2019
Study of PHN131 in Patients After Surgery
(clinicaltrials.gov)
- P2/3; N=106; Completed; Sponsor: PhytoHealth Corporation; Active, not recruiting ➔ Completed; Trial completion date: Feb 2016 ➔ Feb 2019
Clinical • Trial completion • Trial completion date
1 to 3
Of
3
Go to page
1